Filter by: Subject

Filter by: Subject

Results Per Page:

Actinium-225 (2)
Metastatic castration-resistant prostate cancer (mCRPC) (2)
Prostate cancer (2)
Prostate-specific membrane antigen (PSMA) (2)
Bismuth-213 (1)
Chemotherapy-naïve (1)
Prostate-specific antigen (PSA) (1)
PSMA-based alpha therapy (PAT) (1)
Radioligand therapy (1)
Targeted alpha therapy (1)